Rashad Falah: Evaluating Long Term Outcomes and Transfusion Risks in Obscure Gastrointestinal Bleeding
Rashad Falah, Medical Doctor at Rambam Health Care Campus, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in BMC Gastroenterology, adding:
“In our new publication in BMC Gastroenterology (as an equally contributing author), we evaluated long term hematologic outcomes following double balloon enteroscopy (DBE) in patients with obscure gastrointestinal bleeding.
Our study showed that while hemoglobin levels improved overall after DBE, patients requiring therapeutic intervention represented a higher risk subgroup with more severe baseline anemia and persistent transfusion needs despite endoscopic therapy.
These findings support the need for combined endoscopic and adjunctive medical therapy in complex small bowel bleeding.”
Title: Clinical outcomes after deep enteroscopy in patients with obscure gastrointestinal bleeding: a single-center retrospective study
Authors: Nour Ershaid, Rashad Falah, Amir Klein, Itay Maza
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery
-
Aug 31, 2026, 14:06Khalid Alfawaz: Signed Consent Doesn’t Always Mean Informed
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?